Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Return on Capital Employed (2021 - 2025)

Treace Medical Concepts' Return on Capital Employed history spans 5 years, with the latest figure at 0.33% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 2.0% year-over-year to 0.33%; the TTM value through Dec 2025 reached 0.33%, down 2.0%, while the annual FY2025 figure was 0.31%, 3.0% down from the prior year.
  • Return on Capital Employed reached 0.33% in Q4 2025 per TMCI's latest filing, down from 0.3% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.02% in Q1 2021 to a low of 0.34% in Q3 2024.
  • Average Return on Capital Employed over 5 years is 0.23%, with a median of 0.26% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: dropped -22bps in 2022, then increased 5bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.14% in 2021, then plummeted by -100bps to 0.27% in 2022, then grew by 6bps to 0.26% in 2023, then dropped by -21bps to 0.31% in 2024, then decreased by -7bps to 0.33% in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Return on Capital Employed are 0.33% (Q4 2025), 0.3% (Q3 2025), and 0.29% (Q2 2025).